FSTSX
Price
$18.06
Change
+$0.09 (+0.50%)
Updated
May 8 closing price
Net Assets
3.73B
OBIIX
Price
$9.87
Change
+$0.02 (+0.20%)
Updated
May 8 closing price
Net Assets
358.36M
Ad is loading...

FSTSX vs OBIIX

Header iconFSTSX vs OBIIX Comparison
Open Charts FSTSX vs OBIIXBanner chart's image
Fidelity Series International Sm Cap
Price$18.06
Change+$0.09 (+0.50%)
VolumeN/A
Net Assets3.73B
Oberweis International Opps Instl
Price$9.87
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets358.36M
FSTSX vs OBIIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSTSX vs. OBIIX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTSX is a Buy and OBIIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSTSX has more cash in the bank: 3.73B vs. OBIIX (358M). OBIIX (2.93) and FSTSX (2.92) have matching dividends . FSTSX was incepted earlier than OBIIX: FSTSX (15 years) vs OBIIX (11 years). OBIIX (1.10) is less costly to investors than FSTSX (0.02). OBIIX is a more actively managed with annual turnover of: 99.00 vs. FSTSX (30.00). FSTSX has a lower initial minimum investment than OBIIX: FSTSX (0) vs OBIIX (1000000). OBIIX annual gain was more profitable for investors over the last year : 13.08 vs. FSTSX (6.95). FSTSX return over 5 years is better than : 32.55 vs. OBIIX (8.42).
FSTSXOBIIXFSTSX / OBIIX
Total Expense Ratio0.021.102%
Annual Report Gross Expense Ratio0.021.102%
Fund Existence15 years11 years-
Gain YTD10.92611.04899%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.73B358M1,041%
Annual Yield % from dividends2.922.93100%
Returns for 1 year6.9513.0853%
Returns for 3 years24.4717.14143%
Returns for 5 years32.558.42387%
Returns for 10 years22.745.83390%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVPX14.43N/A
N/A
Lord Abbett Fundamental Equity P
FTDZX112.10N/A
N/A
Franklin Biotechnology Discovery Adv
PEIQX38.33N/A
N/A
Principal Equity Income R5
NIEYX16.66N/A
N/A
BNY Mellon International Equity Y
WXCIX12.93N/A
N/A
William Blair Emerg Mkts ex China Gr I